186 related articles for article (PubMed ID: 17612055)
21. Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys.
Miklossy J; Doudet DD; Schwab C; Yu S; McGeer EG; McGeer PL
Exp Neurol; 2006 Feb; 197(2):275-83. PubMed ID: 16336966
[TBL] [Abstract][Full Text] [Related]
22. Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions.
Gibrat C; Saint-Pierre M; Bousquet M; Lévesque D; Rouillard C; Cicchetti F
J Neurochem; 2009 Jun; 109(5):1469-82. PubMed ID: 19457163
[TBL] [Abstract][Full Text] [Related]
23. The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse.
Kurkowska-Jastrzebska I; Wrońska A; Kohutnicka M; Członkowski A; Członkowska A
Exp Neurol; 1999 Mar; 156(1):50-61. PubMed ID: 10192776
[TBL] [Abstract][Full Text] [Related]
24. [The role of JNK pathway in familial Parkinson's disease].
Jankowski M
Postepy Biochem; 2007; 53(3):297-303. PubMed ID: 18399358
[TBL] [Abstract][Full Text] [Related]
25. Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra.
Jiang H; Li LJ; Wang J; Xie JX
Exp Neurol; 2008 Aug; 212(2):532-7. PubMed ID: 18577498
[TBL] [Abstract][Full Text] [Related]
26. Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease.
Marinova-Mutafchieva L; Sadeghian M; Broom L; Davis JB; Medhurst AD; Dexter DT
J Neurochem; 2009 Aug; 110(3):966-75. PubMed ID: 19549006
[TBL] [Abstract][Full Text] [Related]
27. Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra.
Ferrari CC; Pott Godoy MC; Tarelli R; Chertoff M; Depino AM; Pitossi FJ
Neurobiol Dis; 2006 Oct; 24(1):183-93. PubMed ID: 16901708
[TBL] [Abstract][Full Text] [Related]
28. Neuroinflammatory processes in Parkinson's disease.
Hirsch EC; Hunot S; Hartmann A
Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S9-S15. PubMed ID: 15885630
[TBL] [Abstract][Full Text] [Related]
29. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
Aoki E; Yano R; Yokoyama H; Kato H; Araki T
Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004
[TBL] [Abstract][Full Text] [Related]
30. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
[TBL] [Abstract][Full Text] [Related]
31. A neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.
Kawasaki T; Ago Y; Kitao T; Nashida T; Takagi A; Takuma K; Matsuda T
Neuropharmacology; 2008 Oct; 55(5):654-60. PubMed ID: 18573265
[TBL] [Abstract][Full Text] [Related]
32. Risk is in the air: an intranasal MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) rat model of Parkinson's disease.
Prediger RD; Rial D; Medeiros R; Figueiredo CP; Doty RL; Takahashi RN
Ann N Y Acad Sci; 2009 Jul; 1170():629-36. PubMed ID: 19686204
[TBL] [Abstract][Full Text] [Related]
33. The role of iron in Parkinson disease and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
Yantiri F; Andersen JK
IUBMB Life; 1999 Aug; 48(2):139-41. PubMed ID: 10794588
[TBL] [Abstract][Full Text] [Related]
34. Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally.
Ling Z; Zhu Y; Tong Cw; Snyder JA; Lipton JW; Carvey PM
Exp Neurol; 2006 Jun; 199(2):499-512. PubMed ID: 16504177
[TBL] [Abstract][Full Text] [Related]
35. Decreased inflammation and augmented expression of trophic factors correlate with MOG-induced neuroprotection of the injured nigrostriatal system in the murine MPTP model of Parkinson's disease.
Kurkowska-Jastrzebska I; Bałkowiec-Iskra E; Ciesielska A; Joniec I; Cudna A; Zaremba MM; Członkowski A; Członkowska A
Int Immunopharmacol; 2009 Jun; 9(6):781-91. PubMed ID: 19286483
[TBL] [Abstract][Full Text] [Related]
36. Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism.
Ros-Bernal F; Hunot S; Herrero MT; Parnadeau S; Corvol JC; Lu L; Alvarez-Fischer D; Carrillo-de Sauvage MA; Saurini F; Coussieu C; Kinugawa K; Prigent A; Höglinger G; Hamon M; Tronche F; Hirsch EC; Vyas S
Proc Natl Acad Sci U S A; 2011 Apr; 108(16):6632-7. PubMed ID: 21467220
[TBL] [Abstract][Full Text] [Related]
37. Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats.
Rojo AI; Cavada C; de Sagarra MR; Cuadrado A
Exp Neurol; 2007 Nov; 208(1):120-6. PubMed ID: 17880941
[TBL] [Abstract][Full Text] [Related]
38. Tripchlorolide protects against MPTP-induced neurotoxicity in C57BL/6 mice.
Hong Z; Wang G; Gu J; Pan J; Bai L; Zhang S; Chen SD
Eur J Neurosci; 2007 Sep; 26(6):1500-8. PubMed ID: 17714494
[TBL] [Abstract][Full Text] [Related]
39. Modeling neuroinflammatory pathogenesis of Parkinson's disease.
Barnum CJ; Tansey MG
Prog Brain Res; 2010; 184():113-32. PubMed ID: 20887872
[TBL] [Abstract][Full Text] [Related]
40. Fucoidan protects against dopaminergic neuron death in vivo and in vitro.
Luo D; Zhang Q; Wang H; Cui Y; Sun Z; Yang J; Zheng Y; Jia J; Yu F; Wang X; Wang X
Eur J Pharmacol; 2009 Sep; 617(1-3):33-40. PubMed ID: 19545563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]